← Portfolio Scout

Portfolio company

LyGenesis

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Digital Health

About

LyGenesis develops regenerative cell therapies that use lymph nodes as bioreactors to grow functioning organs for patients with end-stage organ failure.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies